Resources and case studies

Physiologically Based Pharmacokinetic modeling (PBPK): A new Paradigm in Drug Development.

 Publications on which at least one of our team members is involved: Absence of QTc prolongation in a thorough QT study with imeglimin, a first in class oral agent for type 2 diabetes mellitus.